The former president of e-mail outsourcer Critical Path Inc. has pleaded guilty to securities fraud, saying he conspired to falsely report the company’s revenue for the third and fourth quarters of ...
TUCSON, Ariz., November 19, 2024 — Critical Path Institute® (C-Path) today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership with The Leona M. and Harry B.
TUCSON, Ariz., October 14, 2025 — Critical Path Institute® (C-Path) announced it has been selected to receive the 2025 Innovation Award by Reagan-Udall Foundation for the FDA, part of the Foundation’s ...
Critical Path Institute's ® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment for type 1 diabetes (T1D). Kyle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results